| X | ||||||||||
- Definition Molecular Templates equity holders ownership interest on a fully diluted basis upon consummation of the transaction. No definition available.
|
| X | ||||||||||
- Definition Exchange ratio of company common stock shares exchanged for each share owned by private molecular stockholders. No definition available.
|
| X | ||||||||||
- Definition Promissory note interest rate. No definition available.
|
| X | ||||||||||
- Definition Promissory Notes Receivable. No definition available.
|
| X | ||||||||||
- Definition Stock option outstanding to purchase common stock. No definition available.
|
| X | ||||||||||
- Definition Threshold equity holders ownership interest. No definition available.
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of input used to measure alternative investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|